ICT enabled Wearable Artificial Kidney and Personal Renal Care System
NEPHRON+ will provide a major leap forward in Renal Care. It aims at a next generation, integrated solution for personalized treatment and management of chronic diseased, end-stage renal patients. It offers an ideal solution for c...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
NEPHRON+ will provide a major leap forward in Renal Care. It aims at a next generation, integrated solution for personalized treatment and management of chronic diseased, end-stage renal patients. It offers an ideal solution for continuous dialysis outside the hospital offering better blood clearance, while patients can stay mobile and active in social and economic life. It relies on an ICT-enabled wearable artificial kidney for on-body blood purification. This blood treatment can be adjusted to personal parameters and can be remotely controlled by clinical specialists. The system allows for real-time, continuous, multiparametric (tele) monitoring of both the patient and the device via innovative sensors. The continuous data collection allows for early detection of anomalies and trend analysis on the health status of the patient, offering learning curves for improved treatment. Hereby, NEPHRON+ guarantees accuracy of measurements and treatment, personalized feedback and advice and provides a basis for education of patients. The patients benefit from lower costs, higher clearance levels, and more comfort which will result in: a) improvement of their health condition, b) longer life expectancy and c) improved economical and social living conditions. The potential applications of NEPHRON+ solution can be exploited further beyond Renal Care patients, such as those with acute blood poisoning, liver disease, cancer and chemotherapy patients suffering from heart rhythm variations, weight loss and in need of controlled chemotherapy medicine release based on body parameter and fluid measurements.